marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Halozyme Therapeutics Balance Sheet 2011-2024 | HALO
Annual Balance Sheet Halozyme Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.27 B | 758 M | 646 M | 282 M | 68.4 M | 33.6 M | 150 M | 6.54 M | 62.7 M | 66.6 M | -68.8 M | -52.8 M | |
Long Term Debt |
1.5 B | 1.49 B | 787 M | 397 M | 383 M | 34.9 M | 125 M | 199 M | 28 M | 49.9 M | 49.8 M | 29.7 M | - |
Long Term Debt Current |
- | 13.3 M | 89.4 M | 397 M | 19.5 M | 91.5 M | 77.2 M | 17.4 M | 21.9 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 388 M | 42 M | 180 M | 239 M | 76.3 M | 100 M | 96.3 M | 66.9 M | 37.6 M |
Total Current Liabilities |
112 M | 131 M | 117 M | 421 M | 85.6 M | 149 M | 131 M | 54.6 M | 62.5 M | 24.3 M | 25.5 M | 18.9 M | 17.3 M |
Total Liabilities |
1.65 B | 1.67 B | - | - | 474 M | 191 M | 312 M | 294 M | 139 M | 125 M | 122 M | 85.9 M | 54.9 M |
Deferred Revenue |
- | - | - | 1.75 M | 4.01 M | 4.25 M | 6.57 M | 4.79 M | 9.3 M | 7.37 M | 7.4 M | 8.89 M | 4.13 M |
Retained Earnings |
90.6 M | 143 M | -58.9 M | -475 M | -604 M | -531 M | -522 M | -585 M | -483 M | -450 M | -382 M | -299 M | -245 M |
Total Assets |
1.73 B | 1.84 B | 1.1 B | 580 M | 566 M | 440 M | 520 M | 262 M | 182 M | 166 M | 102 M | 135 M | 65.8 M |
Cash and Cash Equivalents |
118 M | 234 M | 119 M | 148 M | 120 M | 57.9 M | 169 M | 66.8 M | 43.3 M | 61.4 M | 27.4 M | 99.5 M | 52.4 M |
Book Value |
83.8 M | 170 M | 1.1 B | 580 M | 91.8 M | 249 M | 208 M | -32.5 M | 43 M | 41.4 M | -20 M | 48.9 M | 10.9 M |
Total Shareholders Equity |
83.8 M | 170 M | 197 M | 151 M | 91.8 M | 249 M | 208 M | -32.5 M | 43 M | 41.4 M | -20 M | 48.9 M | 10.9 M |
All numbers in USD currency
Quarterly Balance Sheet Halozyme Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.49 B | 1.49 B | 1.49 B | 1.15 B | 788 M | 787 M | 786 M | 786 M | 785 M | - | - | - | - | 383 M | 383 M | 383 M | 383 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 125 M | 125 M | 125 M | 125 M | 199 M | 199 M | 199 M | 199 M | 28 M | 28 M | 28 M | 28 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 49.8 M | 49.8 M | 49.8 M | 49.8 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.67 B | 1.68 B | 1.66 B | 1.65 B | 1.64 B | 1.66 B | 1.63 B | 1.67 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 667 K | 842 K | 3.25 M | 3.25 M | 3.59 M | 4.13 M | 1.75 M | 1.75 M | 2.24 M | 1.25 M | 1.75 M | 1.75 M | 748 K | 1.75 M | 1.75 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 4.25 M | 4.25 M | 4.25 M | 1.25 M | 6.57 M | 6.57 M | 6.57 M | 6.57 M | 4.79 M | 4.79 M | 4.79 M | 4.79 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 7.37 M | 7.37 M | 7.37 M | 7.37 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 8.89 M | 8.89 M | 8.89 M | 8.89 M | 4.13 M | 4.13 M | 4.13 M | 4.13 M |
Retained Earnings |
398 M | 261 M | 167 M | 90.6 M | 222 M | 140 M | 65.7 M | 143 M | 85.5 M | 23.9 M | 1.2 M | -58.9 M | -126 M | -342 M | -434 M | -475 M | -475 M | -475 M | -475 M | -604 M | -604 M | -604 M | -604 M | -531 M | -531 M | -531 M | -531 M | -522 M | -522 M | -522 M | -522 M | -585 M | -585 M | -585 M | -585 M | -483 M | -483 M | -483 M | -483 M | -450 M | -450 M | -450 M | -450 M | -382 M | -382 M | -382 M | -382 M | -299 M | -299 M | -299 M | -299 M | -245 M | -245 M | -245 M | -245 M |
Total Assets |
2.12 B | 1.97 B | 1.84 B | 1.73 B | 1.89 B | 1.81 B | 1.7 B | 1.84 B | 1.86 B | 1.78 B | 1.16 B | 1.1 B | 1.19 B | 1.03 B | 967 M | 580 M | 580 M | 580 M | 580 M | 566 M | 566 M | 566 M | 566 M | 440 M | 440 M | 440 M | 440 M | 520 M | 520 M | 520 M | 520 M | 262 M | 262 M | 262 M | 262 M | 182 M | 182 M | 182 M | 182 M | 166 M | 166 M | 166 M | 166 M | 102 M | 102 M | 102 M | 102 M | 135 M | 135 M | 135 M | 135 M | 65.8 M | 65.8 M | 65.8 M | 65.8 M |
Cash and Cash Equivalents |
154 M | 188 M | 165 M | 118 M | 274 M | 221 M | 96.9 M | 234 M | 148 M | 91.4 M | 118 M | 119 M | 492 M | 447 M | 499 M | 148 M | 148 M | 148 M | 148 M | 120 M | 120 M | 120 M | 120 M | 57.9 M | 57.9 M | 57.9 M | 57.9 M | 169 M | 169 M | 169 M | 169 M | 66.8 M | 66.8 M | 66.8 M | 66.8 M | 43.3 M | 43.3 M | 43.3 M | 43.3 M | 61.4 M | 61.4 M | 61.4 M | 61.4 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 99.5 M | 99.5 M | 99.5 M | 99.5 M | 52.4 M | 52.8 M | 52.8 M | 52.8 M |
Book Value |
453 M | 289 M | 178 M | 83.8 M | 249 M | 151 M | 65.8 M | 170 M | 1.86 B | 1.78 B | 1.16 B | 1.1 B | 1.19 B | 1.03 B | 967 M | 580 M | 580 M | 580 M | 580 M | 566 M | 566 M | 566 M | 566 M | 440 M | 440 M | 440 M | 440 M | 520 M | 520 M | 520 M | 520 M | 262 M | 262 M | 262 M | 262 M | 182 M | 182 M | 182 M | 182 M | 166 M | 166 M | 166 M | 166 M | 102 M | 102 M | 102 M | 102 M | 135 M | 135 M | 135 M | 135 M | 65.8 M | 65.8 M | 65.8 M | 65.8 M |
Total Shareholders Equity |
453 M | 289 M | 178 M | 83.8 M | 249 M | 151 M | 65.8 M | 170 M | 97 M | 293 M | 260 M | 197 M | 282 M | 120 M | 67.6 M | 151 M | 151 M | 151 M | 151 M | 91.8 M | 91.8 M | 91.8 M | 91.8 M | 249 M | 249 M | 249 M | 249 M | 208 M | 208 M | 208 M | 208 M | -32.5 M | -32.5 M | -32.5 M | -32.5 M | 43 M | 43 M | 43 M | 43 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | -20 M | -20 M | -20 M | -20 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M |
All numbers in USD currency